A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2006
10/26/2006	US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections
10/26/2006	US20060239990 Protein Arginine N-Methyltransferase 2 (PRMT-2)
10/26/2006	US20060239989 Stable and which can be obtained in a large quantity, with a high level of purity and of activity
10/26/2006	US20060239988 Neuronal regeneration and compound administration methods
10/26/2006	US20060239987 Nutritional composition and methods of making and using same
10/26/2006	US20060239986 Method for the formation of hydrogel multilayers through surface initiated photopolymerization
10/26/2006	US20060239974 Enhancing cell migration by increasing telomerase activity
10/26/2006	US20060239972 Adiponectin gene therapy
10/26/2006	US20060239969 Isolated nucleic acid molecule; enhancing immunity to the protein product expressed by the HER2/neu tumor-associated antigen
10/26/2006	US20060239967 Oncolytic virus replicating selectively in tumor cells
10/26/2006	US20060239965 Fusion polypeptide comprising a hyaluronan-binding polypeptide fused to a heterologous polypeptide such as a growth factor, an enzyme that activates a prodrug, an angiogenesis inhibitor, a chemoattractant polypeptide or a matrix metalloproteinase inhibitor; anticancer agents
10/26/2006	US20060239964 Retinal degeneration
10/26/2006	US20060239963 Quil a fraction with low toxicity and use thereof
10/26/2006	US20060239962 Rapid one-step generation of antigen loaded dendritic cell vaccine from precursors
10/26/2006	US20060239960 Polymer-based compositions and conjugates of antimicrobial agents
10/26/2006	US20060239958 Biodegradable and pressure-sensitive material for medical use
10/26/2006	US20060239951 Methods for stimulating hair growth by administering BMPs
10/26/2006	US20060239934 Superior control of blood glucose in diabetes treatment
10/26/2006	US20060239933 Medical product
10/26/2006	US20060239930 Process for nebulizing aqueous compositions containing highly concentrated insulin
10/26/2006	US20060239928 Transmucosal administration of drug compositions for treating and preventing disorders in animals
10/26/2006	US20060239924 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
10/26/2006	US20060239912 Carrier molecules
10/26/2006	DE102005019104A1 New conjugate of fluorescent dye bonded directly to protein, useful for intraoperative representation of tumors, inflammation and lymph nodes
10/26/2006	CA2618721A1 Elimination of heterogeneous or mixed cell population in tumors
10/26/2006	CA2606270A1 Amphiphilic polymers and methods of use thereof
10/26/2006	CA2605421A1 Functions and uses of gpr39 gene in central nervous system in mammals
10/26/2006	CA2605410A1 A therapeutic agent for a .beta. related disorders
10/26/2006	CA2605078A1 Plant-derived elastin binding protein ligands and methods of using the same
10/26/2006	CA2605057A1 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi)
10/26/2006	CA2604675A1 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products
10/26/2006	CA2604604A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists
10/26/2006	CA2604583A1 Compositions and uses of a galectin for treatment of dry eye syndrome
10/26/2006	CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof
10/26/2006	CA2604222A1 Il-21 variants
10/26/2006	CA2603518A1 Nutrient composition for promoting collagen production
10/26/2006	CA2602022A1 Binding immunoglobulin protein (bip) for prevention or treatment of bone conditions or diseases
10/26/2006	CA2601823A1 Therapeutic peptides for the treatment of metastatic cancer
10/26/2006	CA2599525A1 Hiv vif mutants
10/25/2006	EP1715045A2 Recombinant antibodies for human therapy
10/25/2006	EP1715044A2 Human neurexin-like proteins and polynucleotides encoding the same
10/25/2006	EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/25/2006	EP1715042A1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRCITED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME
10/25/2006	EP1715040A2 Zinc finger binding domains for GNN
10/25/2006	EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase
10/25/2006	EP1714981A2 Method for the identification of antigenic peptides
10/25/2006	EP1714980A1 Human receptor proteins, related reagents and methods
10/25/2006	EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/25/2006	EP1714978A1 Peptides useful for diagnosis and therapy of tumors
10/25/2006	EP1714977A2 Synthesis of cyclosporin analogs
10/25/2006	EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission
10/25/2006	EP1714973A1 Substances k01-0509 and process for producing the same
10/25/2006	EP1714661A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
10/25/2006	EP1714658A1 Dietary supplement comprising antioxidant agents and carnitine or a precursor thereof, to be used as an aid to fertility in men and women
10/25/2006	EP1714643A1 Sustained release preparation
10/25/2006	EP1714154A2 Diagnostics and therapeutics for diseases associated with plasma glutamate carboxypeptidase (pgcp)
10/25/2006	EP1714153A2 A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
10/25/2006	EP1713929A2 Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
10/25/2006	EP1713927A2 Diagnostics and therapeutics for diseases associated with puromycin sensitive aminopeptidase npepps (npepps)
10/25/2006	EP1713915A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (MULTIFUNCTIONAL siNA)
10/25/2006	EP1713914A2 MEDICAL TREATMENT USING AN RNAi AGENT TARGETING A HUMAN NOTCH SIGNALLING PATHWAY MEMBER
10/25/2006	EP1713912A1 Modified short interfering rna (modified sirna)
10/25/2006	EP1713907A2 Hybrid proteins of active-site serine beta-lactamase.
10/25/2006	EP1713906A2 Coagulation factor vii/viia variants lacking functional lipid membrane binding domain
10/25/2006	EP1713904A1 Production and purification of recombinant arylsulfatase a
10/25/2006	EP1713780A2 Novel inhibitors of glutaminyl cyclase
10/25/2006	EP1713521A2 Haemostatic sprays and compositions
10/25/2006	EP1713507A2 Adept or gdept production of acetaldehyde
10/25/2006	EP1713501A1 Treatment of neurodegenerative diseases by the use of gpr49
10/25/2006	EP1713500A2 Use of aerosolized antithrombin to treat acute lung injury
10/25/2006	EP1713499A1 Methods and compounds for modulating triglyceride and vldl secretion
10/25/2006	EP1713498A1 Composition comprising polymeric material and uses thereof
10/25/2006	EP1713497A1 Use of factor viia for treating late complications of trauma
10/25/2006	EP1713496A1 Use of factor viia for treating trauma
10/25/2006	EP1713495A2 Method of inducing or modulating immune response
10/25/2006	EP1713494A2 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists
10/25/2006	EP1713493A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
10/25/2006	EP1713462A1 A method of modulating pro-inflammatory and inflammatory activity mediated by c-reactive protein
10/25/2006	EP1713446A2 Ternary non-lamellar lipid compositions
10/25/2006	EP1713441A2 Interleukin-13 antagonist powders, spray-dried particles, and methods
10/25/2006	EP1501925A4 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
10/25/2006	EP1495767B1 Immunoadjuvant
10/25/2006	EP1423417B1 Antibodies recognizing a peptide mimicking a cryptic epitope of gp41 of hiv-1
10/25/2006	EP1373308B1 Antagonist for multimerization of hiv-1 vif protein
10/25/2006	EP1313476B1 Sgk3 used as diagnostic and therapeutic target
10/25/2006	EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1259250B1 Endoparasiticidal agents
10/25/2006	EP1233775B2 Tyrosine- and tryptophan-containing peptides as antioxidants
10/25/2006	EP1173768B1 Methods of diagnosing, prognosing, monitoring the progression or evaluating of a treatment of depression on basis of increased cerebrospinal fluid levels of neurotrophin 3
10/25/2006	EP1153302B1 Diagnostics and therapeutics for macular degeneration
10/25/2006	EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP1097167B1 Neurotrophic growth factor
10/25/2006	EP1079811B1 Biodegradable sustained-release alginate gels
10/25/2006	EP1012286B1 Allelic variant of human stat3
10/25/2006	EP0973802B1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/25/2006	EP0957902B1 System for genetically treating cardiac conduction disturbances
10/25/2006	EP0827408B1 Method of administration of igf-i
10/25/2006	CN1852980A Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist

1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 3163